Aardvark Therapeutics, Inc. — Investor Relations & Filings
Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel, small-molecule therapeutics. The company focuses on activating innate homeostatic pathways to address metabolic diseases and conditions associated with hunger. Its lead product candidate, ARD-101, is an oral investigational drug designed for the treatment of hyperphagia, particularly in rare genetic diseases. ARD-101 functions primarily within the digestive tract by activating bitter taste receptors (TAS2Rs), which triggers the local release of satiety hormones. These hormones then send signals to the brain to suppress hunger. The company aims to become a leader in treating hunger, with potential applications for obesity and related conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-Q - Aardvark Therapeutics, Inc. (0001774857) (Filer) | 2026-05-07 | English | |
| 8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer) | 2026-05-07 | English | |
| 8-K - AARDVARK THERAPEUTICS, INC. (0001774857) (Filer) | 2026-02-27 | English | |
| 8-K Filing | 2026-02-12 | English | |
| 4 Filing | 2026-02-11 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46289437 | 8-K | 2026-05-14 | English | ||
| 43000504 | 10-Q - Aardvark Therapeutics, Inc. (0001774857) (Filer) | 2026-05-07 | English | ||
| 42998112 | 8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer) | 2026-05-07 | English | ||
| 32898064 | 8-K - AARDVARK THERAPEUTICS, INC. (0001774857) (Filer) | 2026-02-27 | English | ||
| 31665776 | 8-K Filing | 2026-02-12 | English | ||
| 31665844 | 4 Filing | 2026-02-11 | English | ||
| 31665764 | 4 Filing | 2026-02-11 | English | ||
| 31665753 | 4 Filing | 2026-02-11 | English | ||
| 31665793 | 8-K Filing | 2026-02-10 | English | ||
| 13177537 | 8-K | 2026-01-12 | English | ||
|
2025
5 filings
| |||||
| 13177541 | 4 | 2025-12-13 | English | ||
| 13177538 | 4 | 2025-12-13 | English | ||
| 13177540 | 8-K | 2025-12-10 | English | ||
| 13177543 | 10-Q | 2025-11-13 | English | ||
| 13177544 | 8-K | 2025-11-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Aardvark Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33333/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33333 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33333 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33333 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33333}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aardvark Therapeutics, Inc. (id: 33333)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.